Huntsman Cancer Institute joins innovative clinical trials program for blood cancers

Huntsman Cancer Institute at the University of Utah (the U) has joined other institutions in an innovative clinical trials program designed to match patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) with a clinical trial specifically designed for the genetic signature of their disease.

Pharmalittle: We’re watching BIO layoffs, AstraZeneca plans to double revenue, and more

Good morning from the Pharmalittle campus, where I’m filling in for Ed. Normally, I’m the type of person who used to press snooze 10 times

May 21, 2024

Immunic to Participate in Industry, Scientific and Investor Conferences in November – Biotech Investments

Issuer: Immunic AG / Key word(s): Conference 29.10.2024 / 11:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate

October 30, 2024

Cantourage Group SE (von NuWays AG) – Biotech Investments

Original-Research: Cantourage Group SE – von NuWays AG Einstufung von NuWays AG zu Cantourage Group SE Unternehmen: Cantourage Group SE ISIN: DE000A3DSV01 Anlass der Studie:

February 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.